Feasibility and oncological outcome of patients achieving non-invasive downstaging after transurethral resection of bladder tumor plus systemic chemotherapy for bladder preservation strategy in muscle-invasive bladder cancer

被引：0

作者：

Onishi, T. ^{[1
]}

Inaba, S. ^{[1
]}

Shibahara, T. ^{[1
]}

Suguno, Y. ^{[2
]}

Inoue, T. ^{[2
]}

Kato, M. ^{[3
]}

Kojima, T. ^{[3
]}

机构：

[1] Ise Redcross Hosp, Dept Urol, Ise, Japan

[2] Mie Univ Hosp, Dept Urol, Tsu, Mie, Japan

[3] Aichi Canc Ctr, Dept Urol, Nagoya, Aichi, Japan

来源：

EUROPEAN UROLOGY | 2024年 / 85卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A0900

引用

页码：S1949 / S1950

页数：2

共 50 条

[31] Bladder preservation in invasive bladder cancer with chemotherapy after radical transurethral resection bladder tumour:: Long-term followup [J].

Palou, J ;

Rodríguez, O ;

Segarra, J ;

Huguet, J ;

Marcuello, E ;

Rosales, A ;

Villavicencio, H .

JOURNAL OF UROLOGY, 2006, 175 (04) :403-403

[32] The Oncologic Benefit of Maximal Transurethral Resection of Bladder Cancer in Muscle Invasive Bladder Tumor [J].

Shen, Chih-Yu ;

Tsai, Yuh-Shyan ;

Ou, Chien-Hui ;

Yang, Wen-Hrong .

INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 :315-315

[33] Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer [J].

Elsayed, Dalia Hamouda ;

Elfarargy, Ola M. ;

Elderey, Mohamed Salah ;

Mandour, Doaa ;

Atef, Nora ;

Hemeda, Rehab ;

Kamel, Mostafa ;

Azony, Ahmed ;

Taha, Heba F. .

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2023, 27 (01) :1-9

[34] The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer [J].

Russell, Christopher M. ;

Lebastchi, Amir H. ;

Borza, Tudor ;

Spratt, Daniel E. ;

Morgan, Todd M. .

BLADDER CANCER, 2016, 2 (04) :381-394

[35] OUTCOMES OF BLADDER PRESERVATION THERAPY ON SURVIVAL IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER [J].

Ozaydin, Sukru ;

Atas, Erman ;

Karadurmus, Nuri ;

Emirzeoglu, Levent ;

Arpaci, Fikret .

ARCHIVOS ESPANOLES DE UROLOGIA, 2020, 73 (01) :41-46

[36] Transurethral tumor resection versus partial cystecomy for bladder preservation for muscle invasive cancer [J].

Leibovici, D ;

Kassouf, W ;

Kamat, AM ;

Pisters, LL ;

Pettaway, CA ;

Dinney, CPN .

JOURNAL OF UROLOGY, 2005, 173 (04) :303-304

[37] Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer [J].

Chyle, V ;

Pollack, A ;

Czerniak, B ;

Stephens, LC ;

Zagars, GK ;

Terry, NHA ;

Meyn, RE .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (02) :281-287

[38] Transurethral Resection of Non-muscle-invasive Bladder Cancer [J].

Babjuk, Marko .

EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (07) :542-548

[39] Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer [J].

Shuaishuai Xu ;

Qiuying Yao ;

Guiqin Liu ;

Di Jin ;

Haige Chen ;

Jianrong Xu ;

Zhicheng Li ;

Guangyu Wu .

European Radiology, 2020, 30 :1804-1812

[40] Combining DWI radiomics features with transurethral resection promotes the differentiation between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer [J].

Xu, Shuaishuai ;

Yao, Qiuying ;

Liu, Guiqin ;

Jin, Di ;

Chen, Haige ;

Xu, Jianrong ;

Li, Zhicheng ;

Wu, Guangyu .

EUROPEAN RADIOLOGY, 2020, 30 (03) :1804-1812

← 1 2 3 4 5 →